News Headline Summary

Mylan Inc (MYL) looses bid to overturn February ruling on Vytorin patents; Merck (MRK) victory will still stand

Reaction details (16:23)

- No immediate reaction seen in Merck shares, trades USD 47.33 last. (+1.07%). Similarly, no reaction has been seen in Mylan shares, trades USD 29.10 last. (+1.91%)

11 Apr 2013 - 16:19 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: